Table 1.
All patients (n = 86) | Patients without AIS (n = 80) | Patients with AIS (n = 6) | |
---|---|---|---|
Age, years, mean ±SD | 66.6 ± 11.1 | 66.5 ± 11.5 | 68.2 ± 2.1 |
Sex | |||
Male, n (%) | 54 (62.8) | 49 (61.3) | 5 (83.3) |
Presenting symptoms | |||
Fever, n (%) | 75 (87.2) | 69 (86.3) | 6 (100) |
Cough, n (%) | 65 (75.6) | 61 (76.3) | 4 (66.7) |
Myalgia, n (%) | 15 (17.4) | 12 (15.0) | 3 (50.0) |
Fatigue, n (%)* | 46 (53.5) | 40 (50.0) | 6 (100) |
Headache, n (%) | 8 (9.3) | 7 (8.8) | 1 (16.7) |
Dizziness, n (%) | 6 (7.0) | 5 (6.3) | 1 (16.7) |
PMH | |||
Hypertension, n (%) | 44 (51.1) | 41 (51.3) | 3 (50.0) |
Diabetes, n (%) | 19 (22.1) | 17 (21.3) | 2 (33.3) |
CAD, n (%) | 16 (18.6) | 14 (17.5) | 2 (33.3) |
Ischemic stroke, n (%) | 7 (8.1) | 5 (6.3) | 2 (33.3) |
Intracranial hemorrhage, n (%) | 4 (4.7) | 4 (5.0) | 0 (0) |
Smoking, n (%) | 12 (14.0) | 11 (13.8) | 1 (16.7) |
Complications | |||
Arrhythmia, n (%) | 29 (33.7) | 28 (35.0) | 1 (16.7) |
AF, n (%) | 16 (18.6) | 15 (18.8) | 1 (16.7) |
Coagulopathy, n (%) | 49 (57.0) | 46 (57.5) | 3 (50.0) |
AKI, n (%) | 35 (40.1) | 31 (38.8) | 4 (66.7) |
Liver injury, n (%) | 34 (39.5) | 32 (40.0) | 2 (33.3) |
Delirium, n (%) | 11 (12.8) | 11 (13.8) | 0 (0) |
Intracerebral hemorrhage, n (%) | 1 (1.2) | 1 (1.3) | 0 (0) |
Hypoxic-ischemic brain injury, n (%) | 2 (2.3) | 2 (2.5) | 0 (0) |
Flaccid paralysis, n (%) | 5 (6.3) | 1 (1.3) | 4 (66.7) |
Rhabdomyolysis | 2 (2.3) | 2 (2.5) | 0 (0) |
Treatment | |||
Antiviral therapy, n (%) | 67 (77.9) | 62 (77.5) | 5 (83.3) |
Immunotherapy, n (%) | |||
IVIg, n (%) | 70 (81.4) | 65 (81.3) | 5 (83.3) |
Steroids, n (%) | 71 (82.6) | 67 (83.8) | 4 (66.7) |
Anticoagulation, n (%)* | 48 (55.8) | 42 (52.5) | 6 (100) |
Aspirin, n (%) | 10 (11.6) | 8 (10.0) | 2 (33.3) |
Invasive MV, n (%) | 70 (81.4) | 64 (80.0) | 6 (100) |
ECMO | 5 (5.8) | 5 (6.3) | 0 (0) |
CRRT, n (%) | 16 (18.6) | 15 (18.8) | 1 (16.7) |
Outcome | |||
Death, n (%)* | 55 (64.0) | 54 (67.5) | 1 (16.7) |
Follow-up duration, d, median (IQR) | 35.0 (20.6, 43.5) |
30.0 (20.0, 39.0) |
66.5 (54.8, 69.3) |
COVID-19, corona virus disease 2019; AIS, acute ischemic stroke; SD, standard deviation; PMH, past medical history; CAD, coronary artery disease; AF, atrial fibrillation; AKI, acute kidney injury; IVIg, intravenous immunoglobulin; MV, mechanical ventilation; ECMO, extracorporeal membrane oxygenation; CRRT, continuous renal replacement therapy; IQR, interquartile range.
P < 0.05.